The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to ...

CAM2029 is a novel depot formulation of octreotide, a somatostatin analogue, administered subcutaneously once monthly.

To help guarantee that women know of this new benefit, most private health plans would be required to disclose that over-the-counter contraception is covered without copayments, the White House noted.

Oral semaglutide is currently approved under the brand name Rybelsus ® as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Based on these findings, ...

HealthDay News — Annual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research letter published online ...

HealthDay News — During the 2023/2024 school year, fewer US kindergarteners had complete vaccinations than in prior years, according to a study published in the October 17 issue of the US Centers for ...

Botox Cosmetic is also indicated for the temporary improvement in appearance of moderate to severe glabellar lines, lateral canthal lines, and forehead lines. The product is supplied as 50 units and ...

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...

Obesity directly affects kidney health and influences chronic kidney disease (CKD) risk and progression through contributing diseases such as type 2 diabetes and hypertension.

The Food and Drug Administration (FDA) announced that it has accepted the New Drug Application (NDA) for UGN-102 for intravesical solution for the treatment of low-grade intermediate-risk non-muscle ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...